CLINICAL TRIALS PROFILE FOR NARDIL

All Clinical Trials for NARDIL

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01253642 ↗	Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel	Terminated	National Cancer Institute (NCI)	Phase 2	2010-07-12	This phase II trial studies how well giving phenelzine sulfate together with docetaxel works in treating patients with prostate cancer that is growing, spreading, or getting worse after first-line therapy with docetaxel. Phenelzine sulfate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Phenelzine sulfate may also help docetaxel work better by making tumor cells more sensitive to the drug. Giving phenelzine sulfate together with docetaxel may kill more tumor cells.
NCT01253642 ↗	Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel	Terminated	The Wayne D. Kuni and Joan E. Kuni Foundation	Phase 2	2010-07-12	This phase II trial studies how well giving phenelzine sulfate together with docetaxel works in treating patients with prostate cancer that is growing, spreading, or getting worse after first-line therapy with docetaxel. Phenelzine sulfate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Phenelzine sulfate may also help docetaxel work better by making tumor cells more sensitive to the drug. Giving phenelzine sulfate together with docetaxel may kill more tumor cells.
NCT01253642 ↗	Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel	Terminated	OHSU Knight Cancer Institute	Phase 2	2010-07-12	This phase II trial studies how well giving phenelzine sulfate together with docetaxel works in treating patients with prostate cancer that is growing, spreading, or getting worse after first-line therapy with docetaxel. Phenelzine sulfate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Phenelzine sulfate may also help docetaxel work better by making tumor cells more sensitive to the drug. Giving phenelzine sulfate together with docetaxel may kill more tumor cells.

Clinical Trial Conditions for NARDIL

Condition Name

Condition Name for NARDIL
Intervention	Trials
Metastatic Prostatic Adenocarcinoma	1
Prostate Adenocarcinoma	1
Recurrent Prostate Cancer	1

Condition MeSH

Condition MeSH for NARDIL
Intervention	Trials
Prostatic Neoplasms	2
Adenocarcinoma	2
Breast Neoplasms	1

Clinical Trial Locations for NARDIL

Trials by Country

Trials by Country for NARDIL
Location	Trials
United States	4
Australia	2
Netherlands	1

Trials by US State

Trials by US State for NARDIL
Location	Trials
California	1
Maryland	1
Washington	1
Oregon	1

Clinical Trial Progress for NARDIL

Clinical Trial Phase

Clinical Trial Phase for NARDIL
Clinical Trial Phase	Trials
Phase 2	2
Phase 1	2
N/A	1

Clinical Trial Status

Clinical Trial Status for NARDIL
Clinical Trial Phase	Trials
Terminated	2
Completed	1
Withdrawn	1

Clinical Trial Sponsors for NARDIL

Sponsor Name

Sponsor Name for NARDIL
Sponsor	Trials
National Cancer Institute (NCI)	2
Central Michigan University	1
Sheppard Pratt Health System	1

Sponsor Type

Sponsor Type for NARDIL
Sponsor	Trials
Other	8
Industry	2
NIH	2